mocetinostat - CISMeF

Preferred Label : mocetinostat;

MeSH note : undergoing phase II clinical trials for treatment of cancer;

CISMeF synonym : MG 0103; MG 4230; MG 4915; MG 5026; MGCD 0103;

MeSH synonym : N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide;

MeSH hyponym : MGCD0103; MGCD-0103; MG4915; MG-4915; MG5206; MG-5026; MG0103; MG-0103; MG4230; MG-4230;

Is substance : O;

UNII : A6GWB8T96J;

InChIKey : HRNLUBSXIHFDHP-UHFFFAOYSA-N;

Details

Origin ID

C523184;

UMLS CUI

C2002471;

Automatic exact mappings (from CISMeF team)
- Mocetinostat [NCIt concept]
MeSH term(s) associated for indexing
- benzamides [MeSH Descriptor]
- pyrimidines [MeSH Descriptor]
Pharmacological action(s)
- histone deacetylase inhibitors [MeSH Descriptor]
Record concept(s)
- MG 0103 [MeSH concept]
- MG 4230 [MeSH concept]
- MG 4915 [MeSH concept]
- MG 5026 [MeSH concept]
- MGCD 0103 [MeSH concept]
- mocetinostat [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Mocetinostat [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients